Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Zoetis agrees to buy fish vaccine maker Pharmaq for $765 mln

Zoetis Inc, an animal heath company, agreed to buy Pharmaq, a pharmaceutical company catering to the aquaculture industry, for $765 million. Pharmaq is considered a market leader in sales of vaccines for farmed fish. Farmed fish account for about half of total fish consumption, up from 15 percent in 1990, the company said in a release. Oslo, Norway-based Pharmaq, which is majority owned by global investment firm Permira, generated around $80 million in revenue in 2014. Zoetis, which was spun off by drug company Pfizer Inc. in 2013, is the world’s leading seller of vaccines and medicines for livestock and household pets by sales.

Tags:

US,PHARMAQ,ZOETIS,United States,Deals,Mergers / Acquisitions / Takeovers,Corporate Events,Health / Medicine,Americas,pharma,pharmaceuticals,marine life,aquaculture,fish farming

Why should I add a proposition?

  • Find counterparties that match your capital requirement or investment criteria
  • Get verified, vetted and analyst-picked introductions to relevant propositions
  • Generate new relationships
  • Add Proposition

Aurigin Updates

© Copyright 2023 AURIGIN, All rights reserved.

Securities are offered through Finalis Securities LLC, member of FINRA / SIPC. Aurigin is not a registered broker-dealer, and Finalis Securities LLC and Aurigin are separate, unaffiliated entities.

www.aurigininc.com is a website operated by Aurigin Inc., a privately held Delaware corporation. Aurigin provides deal origination services. Other services, such as securities-related transactions, are offered separately by Sohil Poojara in their capacity as registered representatives of Finalis Securities LLC, member of FINRA/SIPC.